Investor Alert

London Markets Open in:

Cyclerion Therapeutics Inc.



Market closed

 --Quotes are delayed by 20 min

May 16, 2022, 4:00 p.m.





+0.0049 +0.87%


Volume 103,795

Quotes are delayed by 20 min


Previous close

$ 0.57

$ 0.57


+0.0049 +0.87%

Day low

Day high




52 week low

52 week high




Peter M. Hecht

Peter M. Hecht founded Ironwood Pharmaceuticals, Inc. Presently, Dr. Hecht is Chief Executive Officer & Director at Cyclerion Therapeutics, Inc. He is also on the board of Kallyope, Inc.

In the past he occupied the position of Chief Executive Officer & Director at Ironwood Pharmaceuticals, Inc.

He received a graduate degree and an undergraduate degree from Stanford University and a doctorate from the University of California, Berkeley.


Date Shares Transaction Value
06/03/2021 823,170   Acquisition at $3.28 per share. 2,699,997
05/06/2021 302,000   Acquisition at $2.43 per share. 733,860
05/05/2021 398,001   Acquisition at $2.53 per share. 1,006,942
05/04/2021 300,000   Acquisition at $2.29 per share. 687,000
07/10/2019 2,000   Derivative/Non-derivative trans. at $6.04 per share. 12,080
04/01/2019 485   Award at $0 per share. 0
04/01/2019 485   Award at $0 per share. 0
04/01/2019 485   Award at $0 per share. 0
04/01/2019 221,736   Award at $0 per share. 0

Officers and Executives

Dr. Peter M. Hecht
Chief Executive Officer & Director
Ms. Cheryl Gault
Chief Operating Officer
Ms. Anjeza Gjino
Chief Financial Officer
Mr. Kevin Durfee
Vice President-Information Technology & Facilities
Dr. Andreas Eugen Busch
Chief Scientific Officer
Dr. G. Todd Milne
Senior Vice President-Corporate Development
Dr. Jennifer Chickering
Vice President-Clinical Strategy
Ms. Marsha H. Fanucci
Dr. Errol B. de Souza
Independent Director
Ms. Stephanie Lovell
Independent Director
Dr. Michael E. Mendelsohn
Independent Director
Dr. Ole Isacson
Independent Director
Mr. Terrance G. McGuire
Independent Director
Mr. George H. Conrades
Independent Director
Link to MarketWatch's Slice.